<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Med Virol</journal-id><journal-id journal-id-type="iso-abbrev">J. Med. Virol</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1096-9071</journal-id><journal-id journal-id-type="publisher-id">JMV</journal-id><journal-title-group><journal-title>Journal of Medical Virology</journal-title></journal-title-group><issn pub-type="ppub">0146-6615</issn><issn pub-type="epub">1096-9071</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7003848</article-id><article-id pub-id-type="doi">10.1002/jmv.25614</article-id><article-id pub-id-type="publisher-id">JMV25614</article-id><article-categories><subj-group subj-group-type="overline"><subject>Short Communication</subject></subj-group><subj-group subj-group-type="heading"><subject>Short Communications</subject></subj-group></article-categories><title-group><article-title>Key associations for hepatitis C virus genotypes in the Middle East and North Africa</article-title><alt-title alt-title-type="left-running-head">MAHMUD <sc>et al.</sc></alt-title></title-group><contrib-group><contrib id="jmv25614-cr-0001" contrib-type="author" corresp="yes"><name><surname>Mahmud</surname><given-names>Sarwat</given-names></name><xref ref-type="aff" rid="jmv25614-aff-0001">
<sup>1</sup>
</xref><address><email>sam2072@qatar-med.cornell.edu</email></address></contrib><contrib id="jmv25614-cr-0002" contrib-type="author"><name><surname>Chemaitelly</surname><given-names>Hiam S.</given-names></name><xref ref-type="aff" rid="jmv25614-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jmv25614-cr-0003" contrib-type="author"><name><surname>Kouyoumjian</surname><given-names>Silva P.</given-names></name><xref ref-type="aff" rid="jmv25614-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jmv25614-cr-0004" contrib-type="author"><name><surname>Al Kanaani</surname><given-names>Zaina</given-names></name><xref ref-type="aff" rid="jmv25614-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jmv25614-cr-0005" contrib-type="author" corresp="yes"><name><surname>Abu&#x02010;Raddad</surname><given-names>Laith J.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0790-0506</contrib-id><xref ref-type="aff" rid="jmv25614-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="jmv25614-aff-0002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="jmv25614-aff-0003">
<sup>3</sup>
</xref><address><email>lja2002@qatar-med.cornell.edu</email></address></contrib></contrib-group><aff id="jmv25614-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Infectious Disease Epidemiology Group, Weill Cornell Medicine&#x02010;Qatar</named-content>
<institution>Cornell University, Qatar Foundation&#x02010;Education City</institution>
<city>Doha</city>
<country country="QA">Qatar</country>
</aff><aff id="jmv25614-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Healthcare Policy &#x00026; Research, Weill Cornell Medicine</named-content>
<institution>Cornell University</institution>
<city>New York</city>
<named-content content-type="country-part">New York</named-content>
</aff><aff id="jmv25614-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">College of Health and Life Sciences</named-content>
<institution>Hamad Bin Khalifa University</institution>
<city>Doha</city>
<country country="QA">Qatar</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold> Sarwat Mahmud and Professor Laith J. Abu&#x02010;Raddad, PhD, Infectious Disease Epidemiology Group, Weill Cornell Medicine&#x02010;Qatar, Qatar Foundation&#x02010;Education City, P.O. Box 24144, Doha, Qatar.<break/>
Email: <email>sam2072@qatar-med.cornell.edu</email> (SM) and <email>lja2002@qatar-med.cornell.edu</email> (LJA)<break/></corresp></author-notes><pub-date pub-type="epub"><day>14</day><month>10</month><year>2019</year></pub-date><pub-date pub-type="ppub"><month>3</month><year>2020</year></pub-date><volume>92</volume><issue>3</issue><issue-id pub-id-type="doi">10.1002/jmv.v92.3</issue-id><fpage>386</fpage><lpage>393</lpage><history><date date-type="received"><day>08</day><month>8</month><year>2019</year></date><date date-type="accepted"><day>22</day><month>10</month><year>2019</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 Wiley Periodicals, Inc. <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2019 The Authors. <italic>Journal of Medical Virology</italic> published by Wiley Periodicals, Inc.</copyright-statement><license license-type="creativeCommonsBy-nc-nd"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#x02010;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:JMV-92-386.pdf"/><abstract><title>Abstract</title><p>This study aimed to investigate the epidemiology of hepatitis C virus (HCV) genotypes in the Middle East and North Africa (MENA) through an analytical and quantitative meta&#x02010;regression methodology. For the most common genotypes 1, 3, and 4, country/subregion explained more than 77% of the variation in the distribution of each genotype. Genotype 1 was common across MENA, and was more present in high&#x02010;risk clinical populations than in the general population. Genotype 3 was much more present in Afghanistan, Iran, and Pakistan than the rest of countries, and was associated with transmission through injecting drug use. Genotype 4 was broadly disseminated in Egypt in all populations, with overall limited presence elsewhere. While genotype 2 was more present in high&#x02010;risk clinical populations and people who inject drugs, most of the variation in its distribution remained unexplained. Genotypes 5, 6, and 7 had low or no presence in MENA, limiting the epidemiological inferences that could be drawn. To sum up, geography is the principal determinant of HCV genotype distribution. Genotype 1 is associated with transmission through high&#x02010;risk clinical procedures, while genotype 3 is associated with injecting drug use. These findings demonstrate the power of such analytical approach, which if extended to other regions and globally, can yield relevant epidemiological inferences.</p></abstract><abstract abstract-type="highlights"><title>Highlight</title><p>
<list list-type="bullet"><list-item><p>A novel analytical and quantitative approach was used to investigate the epidemiology of hepatitis C virus (HCV) genotypes in the Middle East and North Africa (MENA).</p></list-item><list-item><p>Geography appeared to be the principal determinant of HCV genotype distribution.</p></list-item><list-item><p>Genotype 1 was common across MENA, and was more present in high&#x02010;risk clinical populations than in the general population.</p></list-item><list-item><p>Genotype 3 was much more present in Afghanistan, Iran, and Pakistan than rest of countries, and was associated with transmission through injecting drug use.</p></list-item><list-item><p>Genotype 4 was broadly disseminated in Egypt in all populations, with overall limited presence elsewhere.</p></list-item><list-item><p>Findings demonstrate the power of such analytical approach, which if extended to other regions and globally, can yield relevant epidemiological inferences.</p></list-item></list>
</p></abstract><kwd-group><kwd id="jmv25614-kwd-0001">genotype</kwd><kwd id="jmv25614-kwd-0002">HCV</kwd><kwd id="jmv25614-kwd-0003">meta&#x02010;regression</kwd><kwd id="jmv25614-kwd-0004">Middle East and North Africa</kwd><kwd id="jmv25614-kwd-0005">transmission</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Qatar National Research Fund </institution><institution-id institution-id-type="open-funder-registry">10.13039/100008982</institution-id></institution-wrap></funding-source><award-id>12S&#x02010;0216&#x02010;190094</award-id><award-id>9&#x02010;040&#x02010;3&#x02010;008</award-id></award-group></funding-group><counts><fig-count count="1"/><table-count count="1"/><page-count count="8"/><word-count count="4237"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March 2020</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.7.5 mode:remove_FC converted:06.02.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="jmv25614-cit-0045">
<string-name>
<surname>Mahmud</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chemaitelly</surname>
<given-names>HS</given-names>
</string-name>, <string-name>
<surname>Kouyoumjian</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Al Kanaani</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>Key associations for hepatitis C virus genotypes in the Middle East and North Africa</article-title>. <source xml:lang="en">J Med Virol</source>. <year>2020</year>;<volume>92</volume>:<fpage>386</fpage>&#x02013;<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.25614</pub-id>
<pub-id pub-id-type="pmid">31663611</pub-id></mixed-citation>
</p></notes></front><body><sec id="jmv25614-sec-0010"><label>1</label><title>INTRODUCTION</title><p>The hepatitis C virus (HCV) is a major global health challenge.<xref rid="jmv25614-bib-0001" ref-type="ref">1</xref> An estimated 20% of all individuals chronically infected with HCV are residing in the Middle East and North Africa (MENA).<xref rid="jmv25614-bib-0002" ref-type="ref">2</xref>, <xref rid="jmv25614-bib-0003" ref-type="ref">3</xref> Chronic HCV infection leads to various morbidities, such as liver fibrosis, cirrhosis, and cancer,<xref rid="jmv25614-bib-0004" ref-type="ref">4</xref> all of which strains healthcare systems.<xref rid="jmv25614-bib-0005" ref-type="ref">5</xref>
</p><p>HCV displays extensive genetic diversity and is categorized into seven genotypes (numbered from 1 to 7).<xref rid="jmv25614-bib-0006" ref-type="ref">6</xref> Although genotypes 1 and 3 are common worldwide,<xref rid="jmv25614-bib-0006" ref-type="ref">6</xref> genotype distribution can vary from one geographical area to another.<xref rid="jmv25614-bib-0006" ref-type="ref">6</xref>, <xref rid="jmv25614-bib-0007" ref-type="ref">7</xref> Specific HCV genotypes have been hypothesized to be associated with specific modes of acquisition, or with specific populations.<xref rid="jmv25614-bib-0006" ref-type="ref">6</xref>, <xref rid="jmv25614-bib-0007" ref-type="ref">7</xref>, <xref rid="jmv25614-bib-0008" ref-type="ref">8</xref> However, any specific genotype circulating within a specific population tends also to be reflective of the circulating genotypes in the wider population of that country.<xref rid="jmv25614-bib-0007" ref-type="ref">7</xref>
</p><p>Delineating the epidemiology of HCV genotypes is critical as it can convey inferences about the modes of transmission and their dynamics in a given population.<xref rid="jmv25614-bib-0006" ref-type="ref">6</xref>, <xref rid="jmv25614-bib-0009" ref-type="ref">9</xref> Despite this, existing studies tend to be descriptive and qualitative in nature.<xref rid="jmv25614-bib-0006" ref-type="ref">6</xref>, <xref rid="jmv25614-bib-0007" ref-type="ref">7</xref>, <xref rid="jmv25614-bib-0008" ref-type="ref">8</xref> Against this background, we aimed to demonstrate, to our knowledge for the first time, an analytical and quantitative approach to investigate the epidemiology of HCV genotypes, through meta&#x02010;regressions, as applied to HCV genotype distribution in MENA. This study is part of the MENA HCV Epidemiology Synthesis Project, an ongoing endeavor to delineate HCV epidemiology and inform key public health research, policy, and programming priorities in MENA.<xref rid="jmv25614-bib-0007" ref-type="ref">7</xref>, <xref rid="jmv25614-bib-0010" ref-type="ref">10</xref>, <xref rid="jmv25614-bib-0011" ref-type="ref">11</xref>, <xref rid="jmv25614-bib-0012" ref-type="ref">12</xref>, <xref rid="jmv25614-bib-0013" ref-type="ref">13</xref>, <xref rid="jmv25614-bib-0014" ref-type="ref">14</xref>, <xref rid="jmv25614-bib-0015" ref-type="ref">15</xref>, <xref rid="jmv25614-bib-0016" ref-type="ref">16</xref>, <xref rid="jmv25614-bib-0017" ref-type="ref">17</xref>, <xref rid="jmv25614-bib-0018" ref-type="ref">18</xref>, <xref rid="jmv25614-bib-0019" ref-type="ref">19</xref>, <xref rid="jmv25614-bib-0020" ref-type="ref">20</xref>, <xref rid="jmv25614-bib-0021" ref-type="ref">21</xref>, <xref rid="jmv25614-bib-0022" ref-type="ref">22</xref>, <xref rid="jmv25614-bib-0023" ref-type="ref">23</xref>, <xref rid="jmv25614-bib-0024" ref-type="ref">24</xref>, <xref rid="jmv25614-bib-0025" ref-type="ref">25</xref>, <xref rid="jmv25614-bib-0026" ref-type="ref">26</xref>
</p></sec><sec id="jmv25614-sec-0020"><label>2</label><title>METHODS</title><p>Studies reporting HCV genotype data were retrieved from the MENA HCV Epidemiology Synthesis Project database,<xref rid="jmv25614-bib-0002" ref-type="ref">2</xref> originally for an earlier study of HCV genotypes in MENA.<xref rid="jmv25614-bib-0007" ref-type="ref">7</xref> This comprehensive database consists of several subdatabases on different HCV epidemiological measures, and was populated through a series of systematic reviews for HCV infection across MENA.<xref rid="jmv25614-bib-0010" ref-type="ref">10</xref>, <xref rid="jmv25614-bib-0011" ref-type="ref">11</xref>, <xref rid="jmv25614-bib-0012" ref-type="ref">12</xref>, <xref rid="jmv25614-bib-0013" ref-type="ref">13</xref>, <xref rid="jmv25614-bib-0014" ref-type="ref">14</xref>, <xref rid="jmv25614-bib-0015" ref-type="ref">15</xref>, <xref rid="jmv25614-bib-0016" ref-type="ref">16</xref>, <xref rid="jmv25614-bib-0017" ref-type="ref">17</xref>, <xref rid="jmv25614-bib-0026" ref-type="ref">26</xref> The reviews followed the same methodology, informed by the Cochrane Collaboration handbook,<xref rid="jmv25614-bib-0027" ref-type="ref">27</xref> and used the Preferred Reporting Items for Systematic reviews and Meta&#x02010;analyses (PRISMA) guidelines<xref rid="jmv25614-bib-0028" ref-type="ref">28</xref> to report their findings.</p><p>In these reviews, genotype information were extracted from individual studies to populate the HCV genotype subdatabase. Participants with untypeable genotype were removed from the sample size of the study. Participants with mixed genotypes contributed separately to the quantification of each genotype. The population of each study was classified into six risk categories based on the exposure risk to HCV infection, as presented in Figure <xref rid="jmv25614-fig-0001" ref-type="fig">1</xref> and as informed by existing literature<xref rid="jmv25614-bib-0029" ref-type="ref">29</xref>, <xref rid="jmv25614-bib-0030" ref-type="ref">30</xref>, <xref rid="jmv25614-bib-0031" ref-type="ref">31</xref> and our earlier studies.<xref rid="jmv25614-bib-0010" ref-type="ref">10</xref>, <xref rid="jmv25614-bib-0011" ref-type="ref">11</xref>, <xref rid="jmv25614-bib-0012" ref-type="ref">12</xref>, <xref rid="jmv25614-bib-0013" ref-type="ref">13</xref>, <xref rid="jmv25614-bib-0014" ref-type="ref">14</xref>, <xref rid="jmv25614-bib-0015" ref-type="ref">15</xref>, <xref rid="jmv25614-bib-0016" ref-type="ref">16</xref>, <xref rid="jmv25614-bib-0017" ref-type="ref">17</xref>, <xref rid="jmv25614-bib-0026" ref-type="ref">26</xref> A total of 175 genotype studies on 15&#x02009;960 participants were included.</p><fig fig-type="Figure" xml:lang="en" id="jmv25614-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Population classification into categories by risk of exposures to hepatitis C virus (HCV) infection</p></caption><graphic id="nlm-graphic-1" xlink:href="JMV-92-386-g001"/></fig><p>Univariable and multivariable random effects meta&#x02010;regressions were conducted for the proportion of each HCV genotype, based on established statistical methodology,<xref rid="jmv25614-bib-0027" ref-type="ref">27</xref> to assess the association between genotype and each of country/subregion and population classification. Variables with a likelihood ratio test <italic>P</italic>&#x02009;&#x0003c;&#x02009;.2 in the univariable analysis qualified for inclusion in the multivariable analysis. Relative risks and adjusted relative risks (ARRs) with a <italic>P</italic> value between .05 and .10 in the multivariable model, for any association between genotype and a given factor, indicated <italic>good evidence</italic> for the association. <italic>P</italic>&#x02009;&#x02264;&#x02009;.05 indicated <italic>strong evidence</italic> for the association.</p></sec><sec id="jmv25614-sec-0030"><label>3</label><title>RESULTS</title><p>The results of the meta&#x02010;regressions are shown in Table <xref rid="jmv25614-tbl-0001" ref-type="table">1</xref> with key results described in the following subsections.</p><table-wrap id="jmv25614-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Univariable and multivariable meta&#x02010;regression models for hepatitis C virus (HCV) genotypes in the Middle East and North Africa (MENA)</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr valign="bottom"><th style="border-bottom:solid 1px #000000" colspan="2" rowspan="2" valign="bottom"/><th style="border-bottom:solid 1px #000000" rowspan="2" valign="bottom" colspan="1">Number of studies</th><th colspan="4" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Univariable analysis</th><th colspan="3" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Multivariable analysis</th></tr><tr style="border-bottom:solid 1px #000000" valign="bottom"><th valign="bottom" rowspan="1" colspan="1">RR (95% CI)</th><th valign="bottom" rowspan="1" colspan="1">
<italic>P</italic> value</th><th valign="bottom" rowspan="1" colspan="1">LR test <italic>P</italic> value</th><th valign="bottom" rowspan="1" colspan="1">Variance explained (adjusted <italic>R</italic>
<sup>2</sup> (%))</th><th valign="bottom" rowspan="1" colspan="1">ARR (95% CI)</th><th valign="bottom" rowspan="1" colspan="1">
<italic>P</italic> value</th><th valign="bottom" rowspan="1" colspan="1">Variance explained (adjusted <italic>R</italic>
<sup>2</sup> (%))</th></tr></thead><tbody valign="top"><tr><td colspan="10" valign="top" rowspan="1">
<bold>Genotype 1</bold>
</td></tr><tr><td rowspan="7" style="padding-left:10%" valign="top" colspan="1">Population classification</td><td valign="top" rowspan="1" colspan="1">General population</td><td valign="top" rowspan="1" colspan="1">32</td><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">High&#x02010;risk clinical populations</td><td valign="top" rowspan="1" colspan="1">63</td><td valign="top" rowspan="1" colspan="1">2.0 (1.4&#x02010;3.0)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.2 (1.0&#x02010;1.5)</td><td valign="top" rowspan="1" colspan="1">.098</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Populations at intermediate risk</td><td valign="top" rowspan="1" colspan="1">16</td><td valign="top" rowspan="1" colspan="1">0.8 (0.4&#x02010;1.6)</td><td valign="top" rowspan="1" colspan="1">.605</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.0 (0.7&#x02010;1.4)</td><td valign="top" rowspan="1" colspan="1">.927</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Populations with liver&#x02010;related conditions</td><td valign="top" rowspan="1" colspan="1">28</td><td valign="top" rowspan="1" colspan="1">0.6 (0.3&#x02010;0.9)</td><td valign="top" rowspan="1" colspan="1">.018</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.1 (0.8&#x02010;1.4)</td><td valign="top" rowspan="1" colspan="1">.619</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">PWID</td><td valign="top" rowspan="1" colspan="1">13</td><td valign="top" rowspan="1" colspan="1">1.2 (0.7&#x02010;2.1)</td><td valign="top" rowspan="1" colspan="1">.569</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">0.9 (0.6&#x02010;1.2)</td><td valign="top" rowspan="1" colspan="1">.378</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Special clinical populations</td><td valign="top" rowspan="1" colspan="1">13</td><td valign="top" rowspan="1" colspan="1">1.5 (0.8&#x02010;3.1)</td><td valign="top" rowspan="1" colspan="1">.210</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.3 (0.9&#x02010;1.9)</td><td valign="top" rowspan="1" colspan="1">.229</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Mixed populations</td><td valign="top" rowspan="1" colspan="1">10</td><td valign="top" rowspan="1" colspan="1">1.1 (0.6&#x02010;2.1)</td><td valign="top" rowspan="1" colspan="1">.784</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1">22.0</td><td valign="top" rowspan="1" colspan="1">0.9 (0.6&#x02010;1.2)</td><td valign="top" rowspan="1" colspan="1">.367</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td rowspan="7" style="padding-left:10%" valign="top" colspan="1">Country/subregion</td><td valign="top" rowspan="1" colspan="1">Egypt</td><td valign="top" rowspan="1" colspan="1">38</td><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Afghanistan</td><td valign="top" rowspan="1" colspan="1">3</td><td valign="top" rowspan="1" colspan="1">5.5 (3.0&#x02010;10.3)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">6.5 (3.3&#x02010;12.8)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Gulf<xref ref-type="fn" rid="jmv25614-tbl1-note-0002">
<sup>a</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1">11</td><td valign="top" rowspan="1" colspan="1">6.8 (4.7&#x02010;9.8)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">6.1 (4.1&#x02010;9.0)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Iran</td><td valign="top" rowspan="1" colspan="1">33</td><td valign="top" rowspan="1" colspan="1">7.7 (5.9&#x02010;10.2)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">7.2 (5.4&#x02010;9.6)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Fertile Crescent<xref ref-type="fn" rid="jmv25614-tbl1-note-0003">
<sup>b</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1">45</td><td valign="top" rowspan="1" colspan="1">5.7 (4.3&#x02010;7.5)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">5.3 (4.0&#x02010;7.1)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Maghreb<xref ref-type="fn" rid="jmv25614-tbl1-note-0004">
<sup>c</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1">29</td><td valign="top" rowspan="1" colspan="1">10.8 (8.3&#x02010;14.2)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">10.2 (7.7&#x02010;13.5)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Pakistan</td><td valign="top" rowspan="1" colspan="1">16</td><td valign="top" rowspan="1" colspan="1">1.4 (1.0&#x02010;2.0)</td><td valign="top" rowspan="1" colspan="1">.075</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1">83.1</td><td valign="top" rowspan="1" colspan="1">1.3 (0.9&#x02010;1.9)</td><td valign="top" rowspan="1" colspan="1">.111</td><td valign="top" rowspan="1" colspan="1">84.4<xref ref-type="fn" rid="jmv25614-tbl1-note-0005">
<sup>d</sup>
</xref>
</td></tr><tr><td colspan="10" valign="top" rowspan="1">
<bold>Genotype 2</bold>
</td></tr><tr><td rowspan="7" style="padding-left:10%" valign="top" colspan="1">Population classification</td><td valign="top" rowspan="1" colspan="1">General population</td><td valign="top" rowspan="1" colspan="1">32</td><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">High&#x02010;risk clinical populations</td><td valign="top" rowspan="1" colspan="1">63</td><td valign="top" rowspan="1" colspan="1">2.9 (1.2&#x02010;7.0)</td><td valign="top" rowspan="1" colspan="1">.020</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">2.3 (1.0&#x02010;5.5)</td><td valign="top" rowspan="1" colspan="1">.056</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Populations at intermediate risk</td><td valign="top" rowspan="1" colspan="1">16</td><td valign="top" rowspan="1" colspan="1">3.9 (1.2&#x02010;12.6)</td><td valign="top" rowspan="1" colspan="1">.025</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">5.1 (1.7&#x02010;15.7)</td><td valign="top" rowspan="1" colspan="1">.005</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Populations with liver&#x02010;related conditions</td><td valign="top" rowspan="1" colspan="1">28</td><td valign="top" rowspan="1" colspan="1">1.6 (0.6&#x02010;4.5)</td><td valign="top" rowspan="1" colspan="1">.364</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.4 (0.5&#x02010;3.8)</td><td valign="top" rowspan="1" colspan="1">.465</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">PWID</td><td valign="top" rowspan="1" colspan="1">13</td><td valign="top" rowspan="1" colspan="1">2.9 (0.8&#x02010;10.5)</td><td valign="top" rowspan="1" colspan="1">.110</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">2.9 (0.9&#x02010;10.0)</td><td valign="top" rowspan="1" colspan="1">.086</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Special clinical populations</td><td valign="top" rowspan="1" colspan="1">13</td><td valign="top" rowspan="1" colspan="1">1.3 (0.3&#x02010;7.0)</td><td valign="top" rowspan="1" colspan="1">.720</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.0 (0.2&#x02010;5.3)</td><td valign="top" rowspan="1" colspan="1">.961</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Mixed populations</td><td valign="top" rowspan="1" colspan="1">10</td><td valign="top" rowspan="1" colspan="1">3.1 (0.9&#x02010;11.0)</td><td valign="top" rowspan="1" colspan="1">.075</td><td valign="top" rowspan="1" colspan="1">.176</td><td valign="top" rowspan="1" colspan="1">3.0</td><td valign="top" rowspan="1" colspan="1">3.0 (0.9&#x02010;9.6)</td><td valign="top" rowspan="1" colspan="1">.069</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td rowspan="7" style="padding-left:10%" valign="top" colspan="1">Country/subregion</td><td valign="top" rowspan="1" colspan="1">Egypt</td><td valign="top" rowspan="1" colspan="1">38</td><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Afghanistan</td><td valign="top" rowspan="1" colspan="1">3</td><td valign="top" rowspan="1" colspan="1">0.6 (0.0&#x02010;25.4)</td><td valign="top" rowspan="1" colspan="1">.774</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">0.4 (0.0&#x02010;21.6)</td><td valign="top" rowspan="1" colspan="1">.668</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Gulf<xref ref-type="fn" rid="jmv25614-tbl1-note-0002">
<sup>a</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1">11</td><td valign="top" rowspan="1" colspan="1">3.8 (1.2&#x02010;11.9)</td><td valign="top" rowspan="1" colspan="1">.021</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">5.0 (1.4&#x02010;17.3)</td><td valign="top" rowspan="1" colspan="1">.012</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Iran</td><td valign="top" rowspan="1" colspan="1">33</td><td valign="top" rowspan="1" colspan="1">1.4 (0.5&#x02010;3.5)</td><td valign="top" rowspan="1" colspan="1">.512</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.4 (0.5&#x02010;4.0)</td><td valign="top" rowspan="1" colspan="1">.576</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Fertile Crescent<xref ref-type="fn" rid="jmv25614-tbl1-note-0003">
<sup>b</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1">45</td><td valign="top" rowspan="1" colspan="1">3.4 (1.3&#x02010;8.9)</td><td valign="top" rowspan="1" colspan="1">.011</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">3.4 (1.3&#x02010;9.2)</td><td valign="top" rowspan="1" colspan="1">.017</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Maghreb<xref ref-type="fn" rid="jmv25614-tbl1-note-0004">
<sup>c</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1">29</td><td valign="top" rowspan="1" colspan="1">7.4 (3.0&#x02010;18.0)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">7.1 (2.6&#x02010;19.2)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Pakistan</td><td valign="top" rowspan="1" colspan="1">16</td><td valign="top" rowspan="1" colspan="1">3.6 (1.4&#x02010;9.5)</td><td valign="top" rowspan="1" colspan="1">.009</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1">23.2</td><td valign="top" rowspan="1" colspan="1">4.8 (1.7&#x02010;13.6)</td><td valign="top" rowspan="1" colspan="1">.003</td><td valign="top" rowspan="1" colspan="1">28.8<xref ref-type="fn" rid="jmv25614-tbl1-note-0005">
<sup>d</sup>
</xref>
</td></tr><tr><td colspan="10" valign="top" rowspan="1">
<bold>Genotype 3</bold>
</td></tr><tr><td rowspan="7" style="padding-left:10%" valign="top" colspan="1">Population classification</td><td valign="top" rowspan="1" colspan="1">General population</td><td valign="top" rowspan="1" colspan="1">32</td><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">High&#x02010;risk clinical populations</td><td valign="top" rowspan="1" colspan="1">63</td><td valign="top" rowspan="1" colspan="1">1.0 (0.5&#x02010;2.2)</td><td valign="top" rowspan="1" colspan="1">.983</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">0.9 (0.6&#x02010;1.4)</td><td valign="top" rowspan="1" colspan="1">.646</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Populations at intermediate risk</td><td valign="top" rowspan="1" colspan="1">16</td><td valign="top" rowspan="1" colspan="1">0.6 (0.2&#x02010;2.2)</td><td valign="top" rowspan="1" colspan="1">.430</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.9 (0.8&#x02010;4.2)</td><td valign="top" rowspan="1" colspan="1">.124</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Populations with liver&#x02010;related conditions</td><td valign="top" rowspan="1" colspan="1">28</td><td valign="top" rowspan="1" colspan="1">1.4 (0.5&#x02010;3.7)</td><td valign="top" rowspan="1" colspan="1">.486</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.3 (0.7&#x02010;2.4)</td><td valign="top" rowspan="1" colspan="1">.330</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">PWID</td><td valign="top" rowspan="1" colspan="1">13</td><td valign="top" rowspan="1" colspan="1">3.1 (1.1&#x02010;8.5)</td><td valign="top" rowspan="1" colspan="1">.029</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.7 (1.0&#x02010;3.0)</td><td valign="top" rowspan="1" colspan="1">.074</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Special clinical populations</td><td valign="top" rowspan="1" colspan="1">13</td><td valign="top" rowspan="1" colspan="1">0.8 (0.2&#x02010;3.4)</td><td valign="top" rowspan="1" colspan="1">.745</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.4 (0.5&#x02010;3.7)</td><td valign="top" rowspan="1" colspan="1">.518</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Mixed populations</td><td valign="top" rowspan="1" colspan="1">10</td><td valign="top" rowspan="1" colspan="1">0.5 (0.1&#x02010;1.6)</td><td valign="top" rowspan="1" colspan="1">.228</td><td valign="top" rowspan="1" colspan="1">.055</td><td valign="top" rowspan="1" colspan="1">13.2</td><td valign="top" rowspan="1" colspan="1">0.8 (0.4&#x02010;1.6)</td><td valign="top" rowspan="1" colspan="1">.525</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td rowspan="7" style="padding-left:10%" valign="top" colspan="1">Country/subregion</td><td valign="top" rowspan="1" colspan="1">Egypt</td><td valign="top" rowspan="1" colspan="1">38</td><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Afghanistan</td><td valign="top" rowspan="1" colspan="1">3</td><td valign="top" rowspan="1" colspan="1">60.9 (21.5&#x02010;172.3)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">45.4 (14.3&#x02010;143.8)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Gulf<xref ref-type="fn" rid="jmv25614-tbl1-note-0002">
<sup>a</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1">11</td><td valign="top" rowspan="1" colspan="1">7.5 (2.5&#x02010;22.9)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">7.5 (2.3&#x02010;24.6)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Iran</td><td valign="top" rowspan="1" colspan="1">33</td><td valign="top" rowspan="1" colspan="1">33.8 (15.6&#x02010;73.0)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">43.9 (18.9&#x02010;101.8)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Fertile Crescent<xref ref-type="fn" rid="jmv25614-tbl1-note-0003">
<sup>b</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1">45</td><td valign="top" rowspan="1" colspan="1">9.2 (4.0&#x02010;21.2)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">11.2 (4.6&#x02010;27.0)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Maghreb<xref ref-type="fn" rid="jmv25614-tbl1-note-0004">
<sup>c</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1">29</td><td valign="top" rowspan="1" colspan="1">4.4 (1.9&#x02010;10.3)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">5.4 (2.2&#x02010;13.1)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Pakistan</td><td valign="top" rowspan="1" colspan="1">16</td><td valign="top" rowspan="1" colspan="1">71.7 (32.4&#x02010;158.9)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1">77.0</td><td valign="top" rowspan="1" colspan="1">69.6 (31.2&#x02010;155.5)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1">77.9<xref ref-type="fn" rid="jmv25614-tbl1-note-0005">
<sup>d</sup>
</xref>
</td></tr><tr><td colspan="10" valign="top" rowspan="1">
<bold>Genotype 4</bold>
</td></tr><tr><td rowspan="7" style="padding-left:10%" valign="top" colspan="1">Population classification</td><td valign="top" rowspan="1" colspan="1">General population</td><td valign="top" rowspan="1" colspan="1">32</td><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">High&#x02010;risk clinical populations</td><td valign="top" rowspan="1" colspan="1">63</td><td valign="top" rowspan="1" colspan="1">0.3 (0.2&#x02010;0.7)</td><td valign="top" rowspan="1" colspan="1">.004</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">0.8 (0.6&#x02010;1.1)</td><td valign="top" rowspan="1" colspan="1">.250</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Populations at intermediate risk</td><td valign="top" rowspan="1" colspan="1">16</td><td valign="top" rowspan="1" colspan="1">1.3 (0.5&#x02010;3.5)</td><td valign="top" rowspan="1" colspan="1">.580</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.0 (0.7&#x02010;1.5)</td><td valign="top" rowspan="1" colspan="1">.915</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Populations with liver&#x02010;related conditions</td><td valign="top" rowspan="1" colspan="1">28</td><td valign="top" rowspan="1" colspan="1">0.8 (0.4&#x02010;1.9)</td><td valign="top" rowspan="1" colspan="1">.654</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.0 (0.7&#x02010;1.3)</td><td valign="top" rowspan="1" colspan="1">.957</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">PWID</td><td valign="top" rowspan="1" colspan="1">13</td><td valign="top" rowspan="1" colspan="1">0.4 (0.1&#x02010;1.2)</td><td valign="top" rowspan="1" colspan="1">.104</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.0 (0.6&#x02010;1.7)</td><td valign="top" rowspan="1" colspan="1">.851</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Special clinical populations</td><td valign="top" rowspan="1" colspan="1">13</td><td valign="top" rowspan="1" colspan="1">1.3 (0.5&#x02010;3.9)</td><td valign="top" rowspan="1" colspan="1">.583</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.0 (0.7&#x02010;1.5)</td><td valign="top" rowspan="1" colspan="1">.985</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Mixed populations</td><td valign="top" rowspan="1" colspan="1">10</td><td valign="top" rowspan="1" colspan="1">0.6 (0.2&#x02010;1.8)</td><td valign="top" rowspan="1" colspan="1">.341</td><td valign="top" rowspan="1" colspan="1">.007</td><td valign="top" rowspan="1" colspan="1">9.9</td><td valign="top" rowspan="1" colspan="1">0.8 (0.5&#x02010;1.3)</td><td valign="top" rowspan="1" colspan="1">.348</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td rowspan="7" style="padding-left:10%" valign="top" colspan="1">Country/subregion</td><td valign="top" rowspan="1" colspan="1">Egypt</td><td valign="top" rowspan="1" colspan="1">38</td><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Afghanistan</td><td valign="top" rowspan="1" colspan="1">3</td><td valign="top" rowspan="1" colspan="1">0.0 (0.0&#x02010;0.5)</td><td valign="top" rowspan="1" colspan="1">.023</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">0.0 (0.0&#x02010;0.5)</td><td valign="top" rowspan="1" colspan="1">.021</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Gulf<xref ref-type="fn" rid="jmv25614-tbl1-note-0002">
<sup>a</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1">11</td><td valign="top" rowspan="1" colspan="1">0.5 (0.4&#x02010;0.7)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">0.5 (0.3&#x02010;0.8)</td><td valign="top" rowspan="1" colspan="1">.002</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Iran</td><td valign="top" rowspan="1" colspan="1">33</td><td valign="top" rowspan="1" colspan="1">0.0 (0.0&#x02010;0.0)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">0.0 (0.0&#x02010;0.1)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Fertile Crescent<xref ref-type="fn" rid="jmv25614-tbl1-note-0003">
<sup>b</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1">45</td><td valign="top" rowspan="1" colspan="1">0.6 (0.5&#x02010;0.8)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">0.6 (0.5&#x02010;0.8)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Maghreb<xref ref-type="fn" rid="jmv25614-tbl1-note-0004">
<sup>c</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1">29</td><td valign="top" rowspan="1" colspan="1">0.1 (0.1&#x02010;0.1)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">0.1 (0.1&#x02010;0.1)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Pakistan</td><td valign="top" rowspan="1" colspan="1">16</td><td valign="top" rowspan="1" colspan="1">0.0 (0.0&#x02010;0.1)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1">91.1</td><td valign="top" rowspan="1" colspan="1">0.0 (0.0&#x02010;0.1)</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1">90.3<xref ref-type="fn" rid="jmv25614-tbl1-note-0005">
<sup>d</sup>
</xref>
</td></tr><tr><td colspan="10" valign="top" rowspan="1">
<bold>Genotype 5</bold>
</td></tr><tr><td rowspan="7" style="padding-left:10%" valign="top" colspan="1">Population classification</td><td valign="top" rowspan="1" colspan="1">General population</td><td valign="top" rowspan="1" colspan="1">32</td><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">High&#x02010;risk clinical populations</td><td valign="top" rowspan="1" colspan="1">63</td><td valign="top" rowspan="1" colspan="1">0.3 (0.1&#x02010;1.0)</td><td valign="top" rowspan="1" colspan="1">.055</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">0.3 (0.1&#x02010;1.2)</td><td valign="top" rowspan="1" colspan="1">.087</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Populations at intermediate risk</td><td valign="top" rowspan="1" colspan="1">16</td><td valign="top" rowspan="1" colspan="1">0.6 (0.1&#x02010;3.7)</td><td valign="top" rowspan="1" colspan="1">.540</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">0.7 (0.1&#x02010;4.6)</td><td valign="top" rowspan="1" colspan="1">.694</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Populations with liver&#x02010;related conditions</td><td valign="top" rowspan="1" colspan="1">28</td><td valign="top" rowspan="1" colspan="1">0.7 (0.2&#x02010;2.7)</td><td valign="top" rowspan="1" colspan="1">.594</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.0 (0.2&#x02010;4.2)</td><td valign="top" rowspan="1" colspan="1">.956</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">PWID</td><td valign="top" rowspan="1" colspan="1">13</td><td valign="top" rowspan="1" colspan="1">1.1 (0.2&#x02010;5.7)</td><td valign="top" rowspan="1" colspan="1">.875</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.9 (0.3&#x02010;10.9)</td><td valign="top" rowspan="1" colspan="1">.478</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Special clinical populations</td><td valign="top" rowspan="1" colspan="1">13</td><td valign="top" rowspan="1" colspan="1">6.6 (1.4&#x02010;30.2)</td><td valign="top" rowspan="1" colspan="1">.015</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">12.2 (2.4&#x02010;62.7)</td><td valign="top" rowspan="1" colspan="1">.003</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Mixed populations</td><td valign="top" rowspan="1" colspan="1">10</td><td valign="top" rowspan="1" colspan="1">0.1 (0.0&#x02010;0.8)</td><td valign="top" rowspan="1" colspan="1">.031</td><td valign="top" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" rowspan="1" colspan="1">45.9</td><td valign="top" rowspan="1" colspan="1">0.2 (0.0&#x02010;1.2)</td><td valign="top" rowspan="1" colspan="1">.080</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td rowspan="7" style="padding-left:10%" valign="top" colspan="1">Country/subregion</td><td valign="top" rowspan="1" colspan="1">Egypt</td><td valign="top" rowspan="1" colspan="1">38</td><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1</td><td valign="top" rowspan="1" colspan="1">&#x022ef;</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Afghanistan</td><td valign="top" rowspan="1" colspan="1">3</td><td valign="top" rowspan="1" colspan="1">1.7 (0.0&#x02010;86.2)</td><td valign="top" rowspan="1" colspan="1">.778</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.0 (0.0&#x02010;59.0)</td><td valign="top" rowspan="1" colspan="1">.995</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Gulf<xref ref-type="fn" rid="jmv25614-tbl1-note-0002">
<sup>a</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1">11</td><td valign="top" rowspan="1" colspan="1">3.3 (0.6&#x02010;18.9)</td><td valign="top" rowspan="1" colspan="1">.187</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.1 (0.2&#x02010;5.7)</td><td valign="top" rowspan="1" colspan="1">.945</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Iran</td><td valign="top" rowspan="1" colspan="1">33</td><td valign="top" rowspan="1" colspan="1">0.5 (0.1&#x02010;2.1)</td><td valign="top" rowspan="1" colspan="1">.323</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">0.9 (0.2&#x02010;4.5)</td><td valign="top" rowspan="1" colspan="1">.929</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Fertile Crescent<xref ref-type="fn" rid="jmv25614-tbl1-note-0003">
<sup>b</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1">45</td><td valign="top" rowspan="1" colspan="1">2.3 (0.6&#x02010;8.5)</td><td valign="top" rowspan="1" colspan="1">.227</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">4.7 (1.2&#x02010;17.6)</td><td valign="top" rowspan="1" colspan="1">.024</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Maghreb<xref ref-type="fn" rid="jmv25614-tbl1-note-0004">
<sup>c</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1">29</td><td valign="top" rowspan="1" colspan="1">0.5 (0.1&#x02010;2.1)</td><td valign="top" rowspan="1" colspan="1">.313</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1">1.1 (0.2&#x02010;5.5)</td><td valign="top" rowspan="1" colspan="1">.881</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Pakistan</td><td valign="top" rowspan="1" colspan="1">16</td><td valign="top" rowspan="1" colspan="1">0.9 (0.2&#x02010;4.5)</td><td valign="top" rowspan="1" colspan="1">.940</td><td valign="top" rowspan="1" colspan="1">.157</td><td valign="top" rowspan="1" colspan="1">11.5</td><td valign="top" rowspan="1" colspan="1">1.2 (0.3&#x02010;5.8)</td><td valign="top" rowspan="1" colspan="1">.789</td><td valign="top" rowspan="1" colspan="1">57.3<xref ref-type="fn" rid="jmv25614-tbl1-note-0005">
<sup>d</sup>
</xref>
</td></tr></tbody></table><table-wrap-foot><fn id="jmv25614-tbl1-note-0001"><p>Abbreviations: ARR, adjusted relative risk; CI, confidence interval; LR, likelihood ratio; PWID, people who inject drugs; RR, relative risk.</p></fn><fn id="jmv25614-tbl1-note-0002"><label><sup>a</sup></label><p>Countries include Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates.</p></fn><fn id="jmv25614-tbl1-note-0003"><label><sup>b</sup></label><p>Countries include Iraq, Jordan, Lebanon, Palestine, and Syria.</p></fn><fn id="jmv25614-tbl1-note-0004"><label><sup>c</sup></label><p>Countries include Algeria, Libya, Mauritania, Morocco, and Tunisia.</p></fn><fn id="jmv25614-tbl1-note-0005"><label><sup>d</sup></label><p>The adjusted R&#x02010;squared for the full model.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><sec id="jmv25614-sec-0040"><label>3.1</label><title>Genotype 1</title><p>There was strong evidence for variation in genotype 1 distribution by country/subregion, and good evidence for variation by population. Relative to Egypt, all countries/subregions had much higher presence of genotype 1, apart from Pakistan. Genotype 1 was also more present in high&#x02010;risk clinical populations (ARR of 1.2 [95% confidence interval [CI]:1.0&#x02010;1.5]) than in the general population. Country/subregion and population explained the vast majority of the variation in genotype 1 distribution (84.4%), mostly through the country/subregion variable.</p></sec><sec id="jmv25614-sec-0050"><label>3.2</label><title>Genotype 2</title><p>There was strong evidence for variation in genotype 2 distribution by country/subregion and by population. Relative to Egypt, the Gulf, Fertile Crescent, Maghreb, and Pakistan had higher presence of genotype 2. Genotype 2 was also more present in high&#x02010;risk clinical populations, populations at intermediate risk, and people who inject drugs (PWID), relative to the general population. Country/subregion and population explained only 28.8% of the variation in genotype 2 distribution, mostly through the country/subregion variable, with most variation remaining unexplained.</p></sec><sec id="jmv25614-sec-0060"><label>3.3</label><title>Genotype 3</title><p>There was strong evidence for variation in genotype 3 distribution by country/subregion, and good evidence for variation by population. Relative to Egypt, all countries/subregions had substantially higher presence of genotype 3. This was particularly so for Afghanistan, Iran, and Pakistan, that had much higher presence of this genotype. Genotype 3 was also more present in PWID (ARR of 1.7 [95% CI: 1.0&#x02010;3.0]) than in the general population. Country/subregion and population explained the vast majority of the variation in genotype 3 distribution (77.9%), mostly through the country/subregion variable.</p><p>A sensitivity analysis (Table S1) was performed in which the meta&#x02010;regressions were performed excluding countries in which genotype 3 was the most dominant genotype (Afghanistan and Pakistan but not Iran<xref rid="jmv25614-bib-0007" ref-type="ref">7</xref>). The analysis was conducted to assess the purported global association between this genotype and PWID.<xref rid="jmv25614-bib-0006" ref-type="ref">6</xref> It was found that there is indeed strong evidence for an association between this genotype and PWID (ARR of 2.7 [95% CI: 1.2&#x02010;5.8]). The sensitivity analysis also confirmed the strong evidence for variation by country/subregion&#x02014;country/subregion and population explained the majority of the variation (66.4%), mostly through the country/subregion variable.</p></sec><sec id="jmv25614-sec-0070"><label>3.4</label><title>Genotype 4</title><p>There was strong evidence for variation in genotype 4 distribution by country/subregion, with most countries having substantially lower (Gulf and Fertile Crescent), or much lower (Afghanistan, Iran, Maghreb, and Pakistan) presence of this genotype compared with Egypt. No significant evidence was found for variation in genotype 4 distribution by population, probably reflecting the broadly disseminated nature of the genotype 4 epidemic in Egypt.<xref rid="jmv25614-bib-0007" ref-type="ref">7</xref>, <xref rid="jmv25614-bib-0010" ref-type="ref">10</xref> Country/subregion and population explained the vast majority of the variation in genotype 4 distribution (90.3%), nearly all of which through the country/subregion variable.</p></sec><sec id="jmv25614-sec-0080"><label>3.5</label><title>Genotype 5</title><p>Unlike the other genotypes, most of the variation in the distribution of genotype 5 was explained by the population variable, rather than the country/subregion variable. Paradoxically also, compared with the general population, there was strong evidence for <italic>higher</italic> presence of this genotype in special clinical populations, but <italic>lower</italic> presence in high&#x02010;risk clinical populations. Moreover, of all countries/subregions, only the Fertile Crescent had higher presence of genotype 5 relative to Egypt. Population and country/subregion explained 57.3% of the variation in genotype 5 distribution. These results, which are epidemiologically not easy to interpret, could be an artifact of the very low presence of this genotype in the MENA region.<xref rid="jmv25614-bib-0007" ref-type="ref">7</xref> Genotype 5 was identified in only 3.9% of all genotype studies, with only 0.1% of infections being with this genotype.</p></sec><sec id="jmv25614-sec-0090"><label>3.6</label><title>Genotype 6 and genotype 7</title><p>There were too few studies in which genotype 6 was identified (1.7%), resulting in very broad confidence intervals of limited implications, thus no analyses are reported for this genotype. No study identified the presence of genotype 7 in MENA.</p></sec></sec><sec id="jmv25614-sec-0100"><label>4</label><title>DISCUSSION</title><p>We used a quantitative analytical approach to investigate epidemiological associations for HCV genotypes, with application to the MENA region. The utility of this approach was demonstrated&#x02014;the study yielded estimates for the differences in genotype distributions by country/subregion and by population type. Overall, country/subregion explained most of the variation, highlighting geography as the <italic>principal</italic> determinant of genotype distribution. Interestingly, we found evidence for an association between genotype 1 and high&#x02010;risk clinical populations, possibly explaining, with the global presence of these populations, the common presence of this genotype across countries.<xref rid="jmv25614-bib-0006" ref-type="ref">6</xref> This finding also supports existing literature suggesting such an association.<xref rid="jmv25614-bib-0006" ref-type="ref">6</xref> We further found an association between genotype 3 and PWID, thereby supporting an apparently global role for this genotype in HCV transmission through injecting drug use.<xref rid="jmv25614-bib-0006" ref-type="ref">6</xref> While these findings were generated for MENA, they may reflect generic results of global relevance.</p><p>Genotype epidemiology in the region may have been influenced by several factors. The importation of contaminated blood products, before the onset of blood screening, primarily from Western countries, has been linked to a fraction of reported HIV cases,<xref rid="jmv25614-bib-0032" ref-type="ref">32</xref>, <xref rid="jmv25614-bib-0033" ref-type="ref">33</xref> and presumably helped disseminate HCV genotype 1 across the region.<xref rid="jmv25614-bib-0006" ref-type="ref">6</xref> Genotype 1 was ubiquitous across most countries and subregions of MENA, which may also be attributed to population movement links to countries outside of MENA, as genotype 1 is the most common genotype globally.<xref rid="jmv25614-bib-0006" ref-type="ref">6</xref>, <xref rid="jmv25614-bib-0030" ref-type="ref">30</xref> For example, the presence of genotype 1 was highest in the Maghreb subregion, almost 11&#x02010;fold higher than in Egypt, a subregion which has strong migration links with western and southern Europe.<xref rid="jmv25614-bib-0034" ref-type="ref">34</xref>, <xref rid="jmv25614-bib-0035" ref-type="ref">35</xref>
</p><p>The emerging HIV epidemics among PWID in MENA, and specifically in Afghanistan, Iran, and Pakistan, have been linked to overlapping injecting networks across these countries.<xref rid="jmv25614-bib-0036" ref-type="ref">36</xref>, <xref rid="jmv25614-bib-0037" ref-type="ref">37</xref>, <xref rid="jmv25614-bib-0038" ref-type="ref">38</xref> This may have (partially) contributed to the relatively larger presence of genotype 3 among PWID in these countries. A strong presence of genotype 4 was found in Egypt. Phylogenetic evidence has shown that genotype 4 in this country originated from central Africa,<xref rid="jmv25614-bib-0039" ref-type="ref">39</xref> and circulated endemically until the mass expansion of the HCV epidemic through the parenteral antischistosomal therapy (PAT) campaigns and other healthcare practices.<xref rid="jmv25614-bib-0010" ref-type="ref">10</xref>, <xref rid="jmv25614-bib-0011" ref-type="ref">11</xref>, <xref rid="jmv25614-bib-0039" ref-type="ref">39</xref>, <xref rid="jmv25614-bib-0040" ref-type="ref">40</xref>, <xref rid="jmv25614-bib-0041" ref-type="ref">41</xref>, <xref rid="jmv25614-bib-0042" ref-type="ref">42</xref>, <xref rid="jmv25614-bib-0043" ref-type="ref">43</xref> Genotype 4 was also found to be present in countries that host large migrant labor populations from Egypt,<xref rid="jmv25614-bib-0044" ref-type="ref">44</xref> such as in countries of the Fertile Crescent<xref rid="jmv25614-bib-0013" ref-type="ref">13</xref> and Gulf<xref rid="jmv25614-bib-0026" ref-type="ref">26</xref> subregions of MENA.<xref rid="jmv25614-bib-0007" ref-type="ref">7</xref>, <xref rid="jmv25614-bib-0018" ref-type="ref">18</xref>
</p><p>This study had limitations. HCV genotype data were not available for several countries. The number of studies also varied by population type and country/subregion, and the sample size of genotyped individuals was small for a number of studies&#x02014;we may not have had sufficient statistical power to discern specific associations. This may explain the lack of a clear interpretation/identification of epidemiological associations for genotype 5. We assessed associations for specific key factors that were available in extracted data, but we were unable to assess the role of a broader set of factors. This may clarify why most variation in genotype 2 distribution remained unexplained. Despite these limitations, we were able to utilize a breadth of genotype data that was systematically gathered and that allowed us to conduct such analysis, yielding relevant inferences about genotype distribution and HCV transmission dynamics.</p><p>In conclusion, geography appears to be the principal determinant of HCV genotype distribution. Genotype 1 is associated with transmission through high&#x02010;risk clinical procedures, such as blood transfusions, hemodialysis, and medical injections; while genotype 3 is associated with transmission through injecting drug use. These findings demonstrate the power of such an analytical approach, which if extended to other regions and globally, may yield relevant epidemiological inferences that can inform control and treatment programs.</p></sec><sec sec-type="COI-statement" id="jmv25614-sec-0120"><title>CONFLICT OF INTERESTS</title><p>The authors declare that there are no conflict of interests.</p></sec><sec id="jmv25614-sec-0130"><title>AUTHOR CONTRIBUTIONS</title><p>SM conducted data extraction and analyses and wrote the first draft of the paper. LJA conceived and led the design of the study, analyses, and drafting of the article. All authors contributed to the extraction of data and writing of the manuscript.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material content-type="local-data"><caption><p>Supporting information</p></caption><media xlink:href="JMV-92-386-s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="jmv25614-sec-0110"><title>ACKNOWLEDGMENTS</title><p>This publication was made possible by NPRP grant number 12S&#x02010;0216&#x02010;190094 and NPRP grant number 9&#x02010;040&#x02010;3&#x02010;008,&#x000a0;12S&#x02010;0216&#x02010;190094 from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors. The authors are also grateful for support provided by the Biostatistics, Epidemiology, and Biomathematics Research Core at Weill Cornell Medicine&#x02010;Qatar. The open&#x02010;access publication of this article was funded by the Qatar National Library.</p></ack><ref-list content-type="cited-references" id="jmv25614-bibl-0001"><title>REFERENCES</title><ref id="jmv25614-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="jmv25614-cit-0001">
<string-name>
<surname>Stanaway</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Flaxman</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Naghavi</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013</article-title>. <source xml:lang="en">Lancet</source>. <year>2016</year>;<volume>388</volume>(<issue>10049</issue>):<fpage>1081</fpage>&#x02010;<lpage>1088</lpage>.<pub-id pub-id-type="pmid">27394647</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0002"><label>2</label><mixed-citation publication-type="book" id="jmv25614-cit-0002">
<string-name>
<surname>Chemaitelly</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Mahmud</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chaabna</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kouyoumjian</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Mumtaz</surname>
<given-names>GR</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <source xml:lang="en">The Epidemiology of Hepatitis C Virus in the World Health Organization Eastern Mediterranean Region: Implications for Strategic Action</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2019</year>.</mixed-citation></ref><ref id="jmv25614-bib-0003"><label>3</label><mixed-citation publication-type="miscellaneous" id="jmv25614-cit-0003">
<collab collab-type="authors">WHO</collab>
. <article-title>Global Hepatitis Report</article-title>, <year>2017</year>; 2017. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/">http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/</ext-link>
</mixed-citation></ref><ref id="jmv25614-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jmv25614-cit-0004">
<string-name>
<surname>Lauer</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Walker</surname>
<given-names>BD</given-names>
</string-name>. <article-title>Hepatitis C virus infection</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2001</year>;<volume>345</volume>(<issue>1</issue>):<fpage>41</fpage>&#x02010;<lpage>52</lpage>.<pub-id pub-id-type="pmid">11439948</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="jmv25614-cit-0005">
<string-name>
<surname>Adler</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Goubau</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Nevens</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Van Vlierberghe</surname>
<given-names>H</given-names>
</string-name>. <article-title>Hepatitis C virus: the burden of the disease</article-title>. <source xml:lang="en">Acta Gastroenterol Belg</source>. <year>2002</year>;<volume>65</volume>(<issue>2</issue>):<fpage>83</fpage>&#x02010;<lpage>86</lpage>.<pub-id pub-id-type="pmid">12148444</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="jmv25614-cit-0006">
<string-name>
<surname>Messina</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Humphreys</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Flaxman</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Global distribution and prevalence of hepatitis C virus genotypes</article-title>. <source xml:lang="en">Hepatology</source>. <year>2015</year>;<volume>61</volume>(<issue>1</issue>):<fpage>77</fpage>&#x02010;<lpage>87</lpage>.<pub-id pub-id-type="pmid">25069599</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jmv25614-cit-0007">
<string-name>
<surname>Mahmud</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Al&#x02010;Kanaani</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Chemaitelly</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Chaabna</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kouyoumjian</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>Hepatitis C virus genotypes in the Middle East and North Africa: distribution, diversity, and patterns</article-title>. <source xml:lang="en">J Med Virol</source>. <year>2018</year>;<volume>90</volume>(<issue>1</issue>):<fpage>131</fpage>&#x02010;<lpage>141</lpage>.<pub-id pub-id-type="pmid">28842995</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jmv25614-cit-0008">
<string-name>
<surname>Robaeys</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bielen</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Azar</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Razavi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Nevens</surname>
<given-names>F</given-names>
</string-name>. <article-title>Global genotype distribution of hepatitis C viral infection among people who inject drugs</article-title>. <source xml:lang="en">J Hepatol</source>. <year>2016</year>;<volume>65</volume>(<issue>1</issue>):<fpage>1094</fpage>&#x02010;<lpage>1103</lpage>.<pub-id pub-id-type="pmid">27520879</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jmv25614-cit-0009">
<string-name>
<surname>Zein</surname>
<given-names>NN</given-names>
</string-name>. <article-title>Clinical significance of hepatitis C virus genotypes</article-title>. <source xml:lang="en">Clin Microbiol Rev</source>. <year>2000</year>;<volume>13</volume>(<issue>2</issue>):<fpage>223</fpage>&#x02010;<lpage>235</lpage>.<pub-id pub-id-type="pmid">10755999</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="jmv25614-cit-0010">
<string-name>
<surname>Kouyoumjian</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chemaitelly</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta&#x02010;analyses, and meta&#x02010;regressions</article-title>. <source xml:lang="en">Sci Rep</source>. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>1661</fpage>.<pub-id pub-id-type="pmid">29374178</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="jmv25614-cit-0011">
<string-name>
<surname>Mohamoud</surname>
<given-names>YA</given-names>
</string-name>, <string-name>
<surname>Mumtaz</surname>
<given-names>GR</given-names>
</string-name>, <string-name>
<surname>Riome</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis</article-title>. <source xml:lang="en">BMC Infect Dis</source>. <year>2013</year>;<volume>13</volume>(<issue>1</issue>):<fpage>288</fpage>.<pub-id pub-id-type="pmid">23799878</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="jmv25614-cit-0012">
<string-name>
<surname>Mahmud</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Akbarzadeh</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>The epidemiology of hepatitis C virus in Iran: systematic review and meta&#x02010;analyses</article-title>. <source xml:lang="en">Sci Rep</source>. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>150</fpage>.<pub-id pub-id-type="pmid">29317673</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="jmv25614-cit-0013">
<string-name>
<surname>Chemaitelly</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Chaabna</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>The epidemiology of hepatitis C virus in the fertile crescent: systematic review and meta&#x02010;analysis</article-title>. <source xml:lang="en">PLOS One</source>. <year>2015</year>;<volume>10</volume>(<issue>8</issue>):<elocation-id>e0135281</elocation-id>.<pub-id pub-id-type="pmid">26296200</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="jmv25614-cit-0014">
<string-name>
<surname>Fadlalla</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Mohamoud</surname>
<given-names>YA</given-names>
</string-name>, <string-name>
<surname>Mumtaz</surname>
<given-names>GR</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>The epidemiology of hepatitis C virus in the Maghreb region: systematic review and meta&#x02010;analyses</article-title>. <source xml:lang="en">PLOS One</source>. <year>2015</year>;<volume>10</volume>(<issue>3</issue>):<elocation-id>e0121873</elocation-id>.<pub-id pub-id-type="pmid">25803848</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="jmv25614-cit-0015">
<string-name>
<surname>Chaabna</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kouyoumjian</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>Hepatitis C virus epidemiology in Djibouti, Somalia, Sudan, and Yemen: systematic review and meta&#x02010;analysis</article-title>. <source xml:lang="en">PLOS One</source>. <year>2016</year>;<volume>11</volume>(<issue>2</issue>):<elocation-id>e0149966</elocation-id>.<pub-id pub-id-type="pmid">26900839</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="jmv25614-cit-0016">
<string-name>
<surname>Chemaitelly</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Mahmud</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rahmani</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>The epidemiology of hepatitis C virus in Afghanistan: systematic review and meta&#x02010;analysis</article-title>. <source xml:lang="en">Int J Infect Dis</source>. <year>2015</year>;<volume>40</volume>:<fpage>54</fpage>&#x02010;<lpage>63</lpage>.<pub-id pub-id-type="pmid">26417880</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="jmv25614-cit-0017">
<string-name>
<surname>Al Kanaani</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Mahmud</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kouyoumjian</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>The epidemiology of hepatitis C virus in Pakistan: systematic review and meta&#x02010;analyses</article-title>. <source xml:lang="en">R Soc Open Science</source>. <year>2018</year>;<volume>5</volume>(<issue>4</issue>):<elocation-id>180257</elocation-id>.</mixed-citation></ref><ref id="jmv25614-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="jmv25614-cit-0018">
<string-name>
<surname>Mahmud</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kouyoumjian</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Al Kanaani</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Chemaitelly</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>Individual&#x02010;level key associations and modes of exposure for hepatitis C virus infection in the Middle East and North Africa: a systematic synthesis</article-title>. <source xml:lang="en">Ann Epidemiol</source>. <year>2018</year>;<volume>28</volume>:<fpage>452</fpage>&#x02010;<lpage>461</lpage>.<pub-id pub-id-type="pmid">29661680</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jmv25614-cit-0019">
<string-name>
<surname>Harfouche</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chemaitelly</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kouyoumjian</surname>
<given-names>SP</given-names>
</string-name>, et al. <article-title>Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta&#x02010;analyses, and meta&#x02010;regressions</article-title>. <source xml:lang="en">PLOS One</source>. <year>2017</year>;<volume>12</volume>(<issue>10</issue>):<elocation-id>e0187177</elocation-id>.<pub-id pub-id-type="pmid">29088252</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jmv25614-cit-0020">
<string-name>
<surname>Harfouche</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chemaitelly</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Mahmud</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Epidemiology of hepatitis C virus among hemodialysis patients in the Middle East and North Africa: systematic syntheses, meta&#x02010;analyses, and meta&#x02010;regressions</article-title>. <source xml:lang="en">Epidemiol Infect</source>. <year>2017</year>;<volume>145</volume>:<fpage>3243</fpage>&#x02010;<lpage>3263</lpage>.<pub-id pub-id-type="pmid">28988562</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="jmv25614-cit-0021">
<string-name>
<surname>Ayoub</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>Impact of treatment on hepatitis C virus transmission and incidence in Egypt: A case for treatment as prevention</article-title>. <source xml:lang="en">J Viral Hepatitis</source>. <year>2017</year>;<volume>24</volume>(<issue>6</issue>):<fpage>486</fpage>&#x02010;<lpage>495</lpage>.</mixed-citation></ref><ref id="jmv25614-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="jmv25614-cit-0022">
<string-name>
<surname>Ayoub</surname>
<given-names>HH</given-names>
</string-name>, <string-name>
<surname>Al Kanaani</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>Characterizing the temporal evolution of the hepatitis C virus epidemic in Pakistan</article-title>. <source xml:lang="en">J Viral Hepatitis</source>. <year>2018</year>;<volume>25</volume>:<fpage>670</fpage>&#x02010;<lpage>679</lpage>.</mixed-citation></ref><ref id="jmv25614-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="jmv25614-cit-0023">
<string-name>
<surname>Chemaitelly</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Mahmud</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kouyoumjian</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Al&#x02010;Kanaani</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Hermez</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>Who to test for hepatitis C virus in the Middle East and North Africa?: Pooled analyses of 2,500 prevalence measures including 49 million tests</article-title>. <source xml:lang="en">Hepatol Commun</source>. <year>2019</year>;<volume>3</volume>:<fpage>325</fpage>&#x02010;<lpage>339</lpage>.<pub-id pub-id-type="pmid">30859146</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="jmv25614-cit-0024">
<string-name>
<surname>Ayoub</surname>
<given-names>HH</given-names>
</string-name>, <string-name>
<surname>Chemaitelly</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Omori</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>Hepatitis C virus infection spontaneous clearance: has it been underestimated?</article-title>
<source xml:lang="en">Int J Infect Dis</source>. <year>2018</year>;<volume>75</volume>:<fpage>60</fpage>&#x02010;<lpage>66</lpage>.<pub-id pub-id-type="pmid">30031139</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="jmv25614-cit-0025">
<string-name>
<surname>Ayoub</surname>
<given-names>HH</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>Treatment as prevention for hepatitis C virus in Pakistan: mathematical modelling projections</article-title>. <source xml:lang="en">BMJ Open</source>. <year>2019</year>;<volume>9</volume>(<issue>5</issue>):<elocation-id>e026600</elocation-id>.</mixed-citation></ref><ref id="jmv25614-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="jmv25614-cit-0026">
<string-name>
<surname>Mohamoud</surname>
<given-names>YA</given-names>
</string-name>, <string-name>
<surname>Riome</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>Epidemiology of hepatitis C virus in the Arabian Gulf countries: systematic review and meta&#x02010;analysis of prevalence</article-title>. <source xml:lang="en">Int J Infect Dis</source>. <year>2016</year>;<volume>46</volume>:<fpage>116</fpage>&#x02010;<lpage>125</lpage>.<pub-id pub-id-type="pmid">26996460</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0027"><label>27</label><mixed-citation publication-type="book" id="jmv25614-cit-0027">
<string-name>
<surname>Higgins</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Green</surname>
<given-names>S</given-names>
</string-name>. <chapter-title>Cochrane handbook for systematic reviews of interventions</chapter-title> Vol <volume>4</volume>
<publisher-loc>Hoboken, New Jersey</publisher-loc>: <publisher-name>John Wiley &#x00026; Sons</publisher-name>; <year>2011</year>.</mixed-citation></ref><ref id="jmv25614-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="jmv25614-cit-0028">
<string-name>
<surname>Moher</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Liberati</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tetzlaff</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Altman</surname>
<given-names>DG</given-names>
</string-name>
<collab collab-type="authors">PRISMA group</collab>
. <article-title>Preferred reporting items for systematic reviews and meta&#x02010;analyses: the PRISMA statement</article-title>. <source xml:lang="en">PLOS Med</source>. <year>2009</year>;<volume>6</volume>:<elocation-id>e1000097</elocation-id>.<pub-id pub-id-type="pmid">19621072</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="jmv25614-cit-0029">
<string-name>
<surname>Lavanchy</surname>
<given-names>D</given-names>
</string-name>. <article-title>Evolving epidemiology of hepatitis C virus</article-title>. <source xml:lang="en">Clin Microbiol Infect</source>. <year>2011</year>;<volume>17</volume>(<issue>2</issue>):<fpage>107</fpage>&#x02010;<lpage>115</lpage>.<pub-id pub-id-type="pmid">21091831</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="jmv25614-cit-0030">
<string-name>
<surname>Gower</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Estes</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Blach</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Razavi&#x02010;Shearer</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Razavi</surname>
<given-names>H</given-names>
</string-name>. <article-title>Global epidemiology and genotype distribution of the hepatitis C virus infection</article-title>. <source xml:lang="en">J Hepatol</source>. <year>2014</year>;<volume>61</volume>(<issue>1 suppl</issue>):<fpage>S45</fpage>&#x02010;<lpage>S57</lpage>.<pub-id pub-id-type="pmid">25086286</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="jmv25614-cit-0031">
<string-name>
<surname>Nelson</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Mathers</surname>
<given-names>BM</given-names>
</string-name>, <string-name>
<surname>Cowie</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews</article-title>. <source xml:lang="en">Lancet</source>. <year>2011</year>;<volume>378</volume>(<issue>9791</issue>):<fpage>571</fpage>&#x02010;<lpage>583</lpage>.<pub-id pub-id-type="pmid">21802134</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0032"><label>32</label><mixed-citation publication-type="book" id="jmv25614-cit-0032">
<string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Akala</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Semini</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Riedner</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Wilson</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Tawil</surname>
<given-names>O</given-names>
</string-name>. <source xml:lang="en">Characterizing the HIV/AIDS Epidemic in the Middle East and North Africa: Time for Strategic Action</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>World Bank</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="jmv25614-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="jmv25614-cit-0033">
<string-name>
<surname>Mohamoud</surname>
<given-names>YA</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>FD</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker</article-title>. <source xml:lang="en">World J Gastroenterol</source>. <year>2014</year>;<volume>20</volume>(<issue>36</issue>):<fpage>12734</fpage>&#x02010;<lpage>12752</lpage>.<pub-id pub-id-type="pmid">25278675</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0034"><label>34</label><mixed-citation publication-type="book" id="jmv25614-cit-0034">
<string-name>
<surname>Sievers</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Fassman</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Bommes</surname>
<given-names>M</given-names>
</string-name>. <source xml:lang="en">Migration from the Middle East and North Africa to Europe: Past Developments, Current Status and Future Potentials</source>. <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Amsterdam University Press</publisher-name>; <year>2014</year>.</mixed-citation></ref><ref id="jmv25614-bib-0035"><label>35</label><mixed-citation publication-type="miscellaneous" id="jmv25614-cit-0035">
<collab collab-type="authors">International Organization for Migration</collab>
. Global migration flows, <year>2015</year>
<ext-link ext-link-type="uri" xlink:href="https://www.iom.int/world-migration">https://www.iom.int/world-migration</ext-link>. Accessed May, 2017.</mixed-citation></ref><ref id="jmv25614-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="jmv25614-cit-0036">
<string-name>
<surname>Mumtaz</surname>
<given-names>GR</given-names>
</string-name>, <string-name>
<surname>Weiss</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>Hepatitis C virus and HIV infections among people who inject drugs in the Middle East and North Africa: a neglected public health burden?</article-title>
<source xml:lang="en">J Int AIDS Soc</source>. <year>2015</year>;<volume>18</volume>(<issue>1</issue>):<elocation-id>20582</elocation-id>.<pub-id pub-id-type="pmid">26221872</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0037"><label>37</label><mixed-citation publication-type="miscellaneous" id="jmv25614-cit-0037">
<string-name>
<surname>Mahmud</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mumtaz</surname>
<given-names>GR</given-names>
</string-name>, <string-name>
<surname>Chemaitelly</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa</article-title>. (under review).</mixed-citation></ref><ref id="jmv25614-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="jmv25614-cit-0038">
<string-name>
<surname>Mumtaz</surname>
<given-names>GR</given-names>
</string-name>, <string-name>
<surname>Weiss</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>SL</given-names>
</string-name>, et al. <article-title>HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis</article-title>. <source xml:lang="en">PLOS Med</source>. <year>2014</year>;<volume>11</volume>(<issue>6</issue>):<elocation-id>e1001663</elocation-id>.<pub-id pub-id-type="pmid">24937136</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="jmv25614-cit-0039">
<string-name>
<surname>Iles</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Raghwani</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Harrison</surname>
<given-names>GLA</given-names>
</string-name>, et al. <article-title>Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa</article-title>. <source xml:lang="en">Virology</source>. <year>2014</year>;<volume>464&#x02010;465</volume>(<issue>100</issue>):<fpage>233</fpage>&#x02010;<lpage>243</lpage>.</mixed-citation></ref><ref id="jmv25614-bib-0040"><label>40</label><mixed-citation publication-type="miscellaneous" id="jmv25614-cit-0040">
<string-name>
<surname>Ayoub</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Chemaitelly</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kouyoumjian</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>
<article-title>Characterizing the historical role of parenteral antischistosomal therapy in hepatitis C virus transmission in Egypt</article-title>. (under review).</mixed-citation></ref><ref id="jmv25614-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="jmv25614-cit-0041">
<string-name>
<surname>Frank</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mohamed</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Strickland</surname>
<given-names>GT</given-names>
</string-name>, et al. <article-title>The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt</article-title>. <source xml:lang="en">Lancet</source>. <year>2000</year>;<volume>355</volume>(<issue>9207</issue>):<fpage>887</fpage>&#x02010;<lpage>891</lpage>.<pub-id pub-id-type="pmid">10752705</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="jmv25614-cit-0042">
<string-name>
<surname>Miller</surname>
<given-names>FD</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source>. <year>2010</year>;<volume>107</volume>(<issue>33</issue>):<fpage>14757</fpage>&#x02010;<lpage>14762</lpage>.<pub-id pub-id-type="pmid">20696911</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="jmv25614-cit-0043">
<string-name>
<surname>Cuadros</surname>
<given-names>DF</given-names>
</string-name>, <string-name>
<surname>Branscum</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>FD</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Raddad</surname>
<given-names>LJ</given-names>
</string-name>. <article-title>Spatial epidemiology of hepatitis C virus infection in Egypt: analyses and implications</article-title>. <source xml:lang="en">Hepatology</source>. <year>2014</year>;<volume>60</volume>(<issue>4</issue>):<fpage>1150</fpage>&#x02010;<lpage>1159</lpage>.<pub-id pub-id-type="pmid">24913187</pub-id></mixed-citation></ref><ref id="jmv25614-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="jmv25614-cit-0044">
<string-name>
<surname>Feiler</surname>
<given-names>G</given-names>
</string-name>. <article-title>Migration and recession: Arab labor mobility in the Middle East, 1982&#x02010;89</article-title>. <source xml:lang="en">Popul Dev Rev</source>. <year>1991</year>;<volume>17</volume>:<fpage>134</fpage>&#x02010;<lpage>155</lpage>.</mixed-citation></ref></ref-list></back></article>